UCSF-Stanford Joint Clinical
Chemistry Fellowship


The UCSF-Stanford Joint Clinical Chemistry Fellowship Program is an ABCC Clinical Laboratory Fellowship that is COMACC accredited through the University of California San Francisco.

The fellowship program seeks to attract individuals of diverse backgrounds and experience interested in pursuing careers in clinical chemistry. The fellowship is open to holders of PhD, MD, or MD/PhD degrees.

Mission Statement

The program offers a two-year fellowship to provide PhD, MD, or MD/PhD scientists with analytical, clinical, research, and management experience toward specialization and board certification in clinical chemistry. The training is conducted at both Stanford University and the University of California San Francisco.

Program Aims

The program is designed to provide training in the operation of a clinical laboratory, quality control and assurance, laboratory management, analytical methodologies, and test interferences. The clinical interpretation and diagnostic relevance of tests are emphasized through clinical consults. Research projects could involve method development, test validation, and clinical and scientific investigation in any of the areas within clinical chemistry. The structure of the program is flexible to afford individualized training based on previous experience.


Submit a letter of intent and curriculum vitae to kara.lynch@ucsf.edu, alan.wu@ucsf.edu, and rubenluo@stanford.edu for initial consideration. Selected applicants will be required to complete a formal application and submit three letters of recommendation. Please refer to the COMACC website for the details of the program accreditation.

Clinical Chemistry Faculty at Stanford University

Ruben Luo, PhD, DABCC

Assistant Professor of Pathology
Associate Director, Clinical Chemistry Laboratory, Stanford Health Care

Ruben Y. Luo, PhD, DABCC is an Assistant Professor of Pathology at Stanford University and Associate Director of Clinical Chemistry Laboratory at Stanford Health Care. He has been dedicated to innovations in translational laboratory medicine: discovery of novel diagnostic markers and innovation of diagnostic technologies. His research focuses on (1) discovering the clinical diagnostic value of molecular characteristics of protein biomarkers, and (2) developing high-resolution mass spectrometry and label-free optical sensing technologies for characterization and accurate measurement of biomarkers. He completed his clinical chemistry fellowship at University of California San Francisco. Prior to the fellowship, he had several years of work experience in the clinical diagnostic industry. He received his PhD in analytical chemistry from Stanford University, and BS in chemistry from Peking University.